Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Prevention of kidney cancer incidence and recurrence: Lifestyle, medication and nutrition

Rana Tahbaz*, Marianne Schmid, Axel S. Merseburger

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

Purpose of review The incidence of kidney cancer rises globally with the highest rates in developed countries. This demonstrates the impact of advanced diagnostic imaging but also rising prevalence of modifiable risk factors such as smoking, obesity and hypertension. A literature search was performed with focus on recent studies on risk factors related to lifestyle, medication and nutrition. Further we searched for the effect of cancer prevention strategies. Recent findings Overall, we included 76 studies of the past 5 years. Based on current evidence smoking tobacco, obesity and hypertension remain established risk factors for kidney cancer. Certain analgesics and consumption of processed meat have been linked to increase development of renal cell carcinoma, although data are limited. Fruits, fiber-rich vegetables, coffee and physical activity may have a protective effect against kidney cancer but causal conclusions are not yet supported. Significantly, there is an increasing evidence of inverse association between moderate alcohol consumption. Summary Overall evidence confirms an effective way to prevent the risk of kidney cancer is maintaining a healthy weight and avoid smoking. State policies should further ensure strategies to raise public awareness and support to adopt healthy lifestyles.

OriginalspracheEnglisch
ZeitschriftCurrent Opinion in Urology
Jahrgang28
Ausgabenummer1
Seiten (von - bis)62-79
Seitenumfang18
ISSN0963-0643
DOIs
PublikationsstatusVeröffentlicht - 01.01.2018

Fördermittel

Nitrite from processed meats and other animal sources were associated with increased clear cell RCC risk a, year; BaP, benzo-a-pyrene und 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine; BI, Brinkmann-Index; BP, blood pressure; ccRCC, clear cell renal cell carcinoma; ChRCC, chromophobe renal cell carcinoma; CSS, cancer specific survival; DM, diabetes mellitus; DSM, disease-specific mortality; EU, European Union; f, female; IARC, International Agency for Research on Cancer; m, male; MET, metabolic equivalent; MetS, metabolic syndrome; MRFIT, Multiple Risk Factor Intervention Trial; NLST, national lung screening trial; OC, oral contraceptive; OM, overall mortality; OR, odds ratio; OS, overall survival; PFS, progression free survival; PhIP, 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine; PLCO, prostate, lung, colorectal and ovarian cancer screening trial; pRCC, papillary renal cell carcinoma; Py, pack years; RCC, renal cell carcinoma; RR, Riva-Rocci; UK, United Kingdom; US(A), United States of America; VAI, Visceral Adipose Index; WCRF, World Cancer Research Fund; WHI, Women’s Health Initiative. National Cancer Institute, National Institutes of Health

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen

Strategische Forschungsbereiche und Zentren

  • Profilbereich: Lübeck Integrated Oncology Network (LION)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Prevention of kidney cancer incidence and recurrence: Lifestyle, medication and nutrition“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren